International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index; 5 of the 68 sources its claims cite were checked for support.
Abstract
In the accompanying comment letter (1), Weinert summarizes published data from the Brazilian Gestational Diabetes Study (2) and comments on applying International Association of Diabetes and Pregnancy Study Groups (IADPSG) Consensus Panel recommendations (3) for the diagnosis of gestational diabetes mellitus (GDM) to that cohort. The Brazilian study provided evidence that adverse perinatal outcomes are associated with levels of maternal glycemia below those diagnostic of GDM by American Diabetes Association or World Health Organization criteria. However, the results were potentially confounded by the treatment of GDM. It did find that women with GDM were at increased risk for some …
Overview
CoChat Summary
## TL;DR
This IADPSG consensus report recommends new gestational diabetes mellitus (GDM) diagnostic thresholds based on HAPO study data, using a 75-g OGTT and outcome-linked glucose cutoffs. It also recommends early detection of overt diabetes in pregnancy and notes that these recommendations will increase the frequency of diagnosed hyperglycemic disorders in pregnancy.
## Key findings
- In the HAPO study, a 75-g OGTT was performed in a heterogeneous, multinational, multicultural, ethnically diverse cohort of approximately 25,000 women in the third trimester; medical caregivers were blinded unless predefined glucose criteria were exceeded.
- The report states that the HAPO data showed continuous, graded associations between maternal glucose and primary outcomes, with no obvious thresholds; associations were also observed for secondary outcomes and did not differ among centers.
- The recommended diagnostic thresholds correspond to glucose levels where odds for birth weight >90th percentile, cord C-peptide >90th percentile, and percent body fat >90th percentile reached 1.75 times the estimated odds at mean glucose values; by these criteria, FPG alone identified 8.3% of the HAPO cohort, FPG plus 1-hour glucose identified an additional 5.7%, and 2-hour glucose another 2.1%, for a total GDM incidence of 17.8%.
- Among the HAPO cohort, 11.1% had only one elevated result, 3.9% had two elevated results, 1.1% had all three elevated, and 1.7% were unblinded because FPG or 2-hour glucose exceeded 5.8 mmol/l (105 mg/dl) or 11.1 mmol/l (200 mg/dl).
## Methods
- Consensus report based on review of the HAPO study, additional unpublished HAPO findings, and other published studies discussed at a June 2008 IADPSG workshop/meeting in Pasadena, followed by consensus panel deliberation.
- HAPO design described as observational: a 75-g OGTT in a large multinational cohort, with blinded caregivers except for preset safety thresholds.
- Thresholds were derived from fully adjusted logistic regression models relating continuous maternal glucose measures (FPG, 1-hour, 2-hour) to outcomes; the panel selected an odds ratio threshold of 1.75 relative to mean glucose values.
## Limitations
- The paper states that recommendations for detecting overt diabetes during pregnancy are based on the opinions of the IADPSG Consensus Panel because prospective studies or appropriately designed clinical trials were not available.
- It states that it was not determined whether universal early testing for overt diabetes is clinically valuable or cost-effective.
- Evident from the text: the HAPO study was observational, not a clinical trial, so the diagnostic thresholds are inferred from associations rather than randomized intervention effects.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
4 Valid · 0 Not valid · 36 Not checked · 22 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Similar associations were also observed for secondary outcomes (25,26).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > THE HAPO STUDY
What the sources say
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
- Supportedcites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 source
The Abstract of our copy states that the predefined primary outcomes (size at birth, cesarean delivery, neonatal hypoglycemia, fetal hyperinsulinemia) were reported elsewhere, and that this report's goals were to examine maternal glycemia against additional/newborn anthropometric outcomes (sum of skin folds, individual skin folds, percent body fat) plus cord C-peptide. The Results report strong, graded, continuous associations for these outcomes (e.g., ORs 1.33–1.47 for percent body fat >90th percentile and 1.28–1.56 for individual skin folds), and the Discussion explicitly says 'This pattern is similar to that reported for maternal glucose and birth weight >90th percentile.' That covers the claim's substance — similar associations for the secondary/additional outcomes — even though the paper does not use the label 'secondary outcomes'. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Associations of LGA and excess adiposity with fetal hyperinsulinemia are strong and independent of confounders (26,37,38).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM
What the sources say
- Supportedcites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 source
In the Results (Table 5), higher cord C-peptide, the paper’s measure of fetal insulin, is strongly associated with birth weight above the 90th percentile and adiposity measures. The Discussion states that the relationships persisted after adjustment for potential confounders. The paper does not claim that every possible confounder was excluded. (LLM, conf=0.92)
- Not checked yetcites [37] Metzger BE Silverman BL Freinkel N Dooley SL Ogata ES Green OC: Amniotic fluid insulin concentration as a predictor of obesity. Arch Dis Child 1990; 65: 1050– 1052 2241225 PMC1590256 source
- Not checked yetcites [38] Weiss PA Haeusler M Tamussino K Haas J: Can glucose tolerance test predict fetal hyperinsulinism? BJOG 2000; 107: 1480– 1485 11192103 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Although not directly comparable, it was concluded that results of the two randomized controlled trials (47,48) and HAPO (25,26) are highly complementary.”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM > Other considerations
What the sources say
- Supportedcites [47] Crowther CA Hiller JE Moss JR McPhee AJ Jeffries WS Robinson JS: Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352: 2477– 2486 15951574 source
The paper identifies itself as a randomized clinical trial and reports its treatment results (secondary outcomes; page unavailable). In the citing sentence, this citation identifies one of the two trials whose results are being discussed; it does not attribute the cross-study judgment of complementarity to this trial paper. (LLM, conf=0.88)
- Not checked yetcites [48] Landon MB Spong CY Thom E Carpenter MW Ramin SM Casey B Wapner RJ Varner MW Rouse DJ Thorp JM Jr Sciscione A Catalano P Harper M Saade G Lain KY Sorokin Y Peaceman AM Tolosa JE Anderson GB: Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009: 361; 1339– 1348. PMC2804874 19797280
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
- Could not verifycites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 sourceExperimental — accuracy not yet measured
The Abstract reports HAPO findings on maternal glucose and pregnancy outcomes, but does not compare them with randomized trials. Searches for randomized trials and for the claimed complementarity found no passage in our copy making that comparison. No page numbers were available. (LLM, conf=0.70)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
In the paper
“Importantly, there were continuous graded relationships between higher maternal glucose and increasing frequency of the primary outcomes, independent of other risk factors (25).”
- Also stated in: § Future considerations · boosted
“The HAPO study was a basic epidemiological investigation that for the first time conclusively identified strong continuous associations of maternal glucose levels below those diagnostic of diabetes with several perinatal outcomes.”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > THE HAPO STUDY
What the sources say
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Future considerations · boosted
None of the sources cited for this claim have been checked yet.
In the paper
“HAPO data show strong linear associations of risks for >90th percentiles of birth weight, cord C-peptide, and percent body fat with each of three measures of maternal glucose (FPG, 1-h, and 2-h post–75-g load).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
40 more claims
Create a free account to see all 62 claims and to verify the 63 references still open.
- It may state two separate claims as one. 10
- Probably not a substantial claim. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“GDM was identified when fasting blood glucose (FBG) ≥ 5.1 mmol/L during the first trimester or any plasma glucose after a 75 g OGTT performed as: FBG ≥ 5.1 mmol/L, 1 h after glucose load ≥ 10.0 mmol/L or 2 h after glucose load ≥ 8.5 mmol/L using the criteria of International Association of Diabetes and Pregnancy Study Groups (IADPSG) [28].”
From Associations of maternal pre-pregnancy BMI and gestational weight gain with the risks of adverse pregnancy outcomes in Chinese women with gestational diabetes mellitus (2023) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“to adopt diagnostic glucose thresholds corresponding to a HAPO OR of 1.75 (fasting plasma glucose [FPG] 5.1–6.9 mmol/L, one‐hour plasma glucose [1hPG] ≥ 10.0 mmol/L, and/or two‐hour plasma glucose [2hPG] 8.5–11.0 mmol/L). 14”
From Australasian Diabetes in Pregnancy Society ( ADIPS ) 2025 consensus recommendations for the screening, diagnosis and classification of gestational diabetes (2025) · cites this paper as [14]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The IADPSG diagnostic thresholds are the first criteria based on risks of adverse perinatal outcomes, rather than risk of subsequent development of maternal diabetes1 or by applying thresholds that define impaired glucose tolerance outside of pregnancy.5,6”
From Gestational Diabetes Mellitus (2019) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“following the diagnostic criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) (18)”
From Diabetes gestacional y riesgo de apnea obstructiva del sueño en el tercer trimestre (2025) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Based on the HAPO Study and other studies, new criteria for the diagnosis of gestational diabetes were proposed by the International Association of Diabetes and Pregnancy Study Groups (IADPSG) 2 and adopted by the World Health Organization and others.3,4”
From Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity (2018) · cites this paper as [2]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Boney, C. M., Verma, A., Tucker, R., & Vohr, B. R. (2005) · Pediatrics · doi:10.1542/peds.2004-1808 · Cited by 2,303 · cited 2×
“Long-term risks associated with fetal macrosomia in infants of women with GDM (independent of confounders) include childhood overweight (43,44) and metabolic factors that may increase risk of cardiovascular disease (CVD) (45).”
BackgroundA Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122
Metzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-s225 · Cited by 1,908
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s062 · Cited by 1,817
(1964) · PubMed · Cited by 1,230
Research works printed but not linked: 2
- Canadian Task Force on the Periodic Health Examination. The Canadian guide to clinical preventive health care. Health Canada 1994; 15– 23
- National Collaborating Centre for Women's and Children's Health. Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. London, U.K., RCOG Press, 2008 21370515
Cited by
Items 301–400 of 1,132
Gestational Diabetes Mellitus: The Impact of Carbohydrate Quality in Diet
Filardi, T., Panimolle, F., Crescioli, C., Lenzi, A., & Morano, S. (2019) · Nutrients · doi:10.3390/nu11071549 · Cited by 111
Sun, Y., Li, X., Benmarhnia, T., Chen, J., Avila, C. C., Sacks, D. A., Chiu, V. Y., Slezak, J. M., Molitor, J., Getahun, D., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.106888 · Cited by 108
“Two criteria for GDM testing were used: the Carpenter-Coustan criteria [a 1-hr 50-g glucose challenge test (GCT) > 200 mg/dL or two abnormal values for 3-hour 100-g oral glucose tolerance test (OGTT), the cutoff values were fasting ≥ 95, 1hr ≥ 180, 2hr ≥ 155, 3hr ≥ 140 mg/dl (Carpenter & Coustan, 1982)]; or the Intern…”
MethodCrume, T., Shapiro, A. L. B., Brinton, J. T., Glueck, D. H., Martinez, M., Kohn, M., Harrod, C. S., Friedman, J. E., & Dabelea, D. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2949 · Cited by 102
Côté, S., Gagné-Ouellet, V., Guay, S.-P., Allard, C., Houde, A.-A., Perron, P., Baillargeon, J.-P., Gaudet, D., Guérin, R., Brisson, D., et al. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0239-9 · Cited by 94
“Gestational diabetes mellitus (GDM) is a form of diabetes first diagnosed in pregnancy, which now affects up to 16 % of pregnant women according to the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) criteria [8].”
BackgroundYing, H., Tang, Y., Bao, Y., Su, X., Cai, X., Li, Y., & Wang, D. (2016) · Endocrine · doi:10.1007/s12020-016-1022-6 · Cited by 102
Daraki, V. N., Georgiou, V., Papavasiliou, S. S., Chalkiadaki, G., Karahaliou, M., Koinaki, S., Sarri, K. O., Vassilaki, M. E., Kogevinas, M., & Chatzi, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126327 · Cited by 103
“Maternal hyperglycemia in early pregnancy was defined as a maternal fasting blood glucose level 92 mg/dl [27].”
BackgroundFarrar, D., Simmonds, M., Bryant, M., Lawlor, D. A., Dunne, F., Tuffnell, D., & Sheldon, T. A. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175288 · Cited by 92
Tieu, J., Middleton, P., McPhee, A. J., & Crowther, C. A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007222.pub2 · Cited by 94
Bodmer-Roy, S., Morin, L., Cousineau, J., & Rey, E. (2012) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31826994ec · Cited by 97
Gestational diabetes in India: Science and society
Mithal, A., Bansal, B., & Kalra, S. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.164031 · Cited by 113
Quilter, C. R., Cooper, W. N., Cliffe, K. M., Skinner, B. M., Prentice, P. M., Nelson, L., Bauer, J., Ong, K. K., Constância, M., Lowe, W. L., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-255240 · Cited by 99
Tieu, J., McPhee, A. J., Crowther, C. A., Middleton, P., & Shepherd, E. S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007222.pub4 · Cited by 123
Absolute Risks of Obstetric Outcomes Risks by Maternal Age at First Birth: A Population-based Cohort
Schummers, L., Hutcheon, J. A., Hacker, M. R., VanderWeele, T. J., Williams, P. L., McElrath, T. F., & Hernandez-Diaz, S. (2018) · Epidemiology · doi:10.1097/ede.0000000000000818 · Cited by 96
Corrado, F., D’Anna, R., Cannata, M. L., Interdonato, M. L., Pintaudi, B., & Di Benedetto, A. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.03.006 · Cited by 96
Garnweidner-Holme, L., Borgen, I., Garitano, I., Noll, J., & Lukasse, M. (2015) · Healthcare · doi:10.3390/healthcare3020310 · Cited by 88
“or first recognition during pregnancy [1], is increasing worldwide.”
BackgroundTsakiridis, I., Giouleka, S., Mamopoulos, A., Kourtis, A., Athanasiadis, A., Filopoulou, D., & Dagklis, T. (2021) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000899 · Cited by 94
The influence of maternal BMI and gestational diabetes on pregnancy outcome
Martin, K. E., Grivell, R. M., Yelland, L. N., & Dodd, J. M. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.12.015 · Cited by 108
“[27] Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al.”
BackgroundMorikawa, M., Yamada, T., Yamada, T., Akaishi, R., Nishida, R., Cho, K., & Minakami, H. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.08.023 · Cited by 103
Ethridge, J. K., Catalano, P. M., & Waters, T. P. (2014) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000412 · Cited by 95
Gomes, D., von Kries, R., Delius, M., Mansmann, U., Nast, M., Stubert, M., Langhammer, L., Haas, N. A., Netz, H., Obermeier, V., et al. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002681 · Cited by 110
Maternal lipid profiles in women with and without gestational diabetes mellitus
Wang, J., Li, Z., & Lin, L. (2019) · Medicine · doi:10.1097/md.0000000000015320 · Cited by 110
Prediction of Gestational Diabetes through NMR Metabolomics of Maternal Blood
Pinto, J., Almeida, L. M., Martins, A. S., Duarte, D., Barros, A. S., Galhano, E. M. B., Pita, C., Almeida, M. D. C., Carreira, I. M., & Gil, A. M. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00260 · Cited by 96
Samimi, M., Jamilian, M., Asemi, Z., & Esmaillzadeh, A. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.06.005 · Cited by 95
“[1] GDM is associated with insulin resistance and increased lipid profiles [2].”
BackgroundRetractedNguyen, D., Hsu Jean, W., Jahoor, F., & Sekhar Rajagopal, V (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2376 · Cited by 93
Gestational Diabetes Management Using Smart Mobile Telemedicine
Rigla, M., Martínez-Sarriegui, I., García-Sáez, G., Pons, B., & Hernando, M. E. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817704442 · Cited by 96
Use of hemoglobin A1c as an early predictor of gestational diabetes mellitus
Fong, A., Serra, A. E., Gabby, L., Wing, D. A., & Berkowitz, K. M. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.06.016 · Cited by 94
Liu, L., Hong, Z., & Zhang, L. (2015) · Scientific Reports · doi:10.1038/srep12863 · Cited by 94
Mantri, N. M., Goel, A. D., Patel, M., Baskaran, P., Dutta, G., Gupta, M. K., Yadav, V., Mittal, M., Shekhar, S., & Bhardwaj, P. (2024) · BMC Public Health · doi:10.1186/s12889-024-18024-9 · Cited by 110
“It’s important to note that the Fasting Plasma Glucose (FPG) parameter from the WHO 1999 criteria is considered outdated now, indicative of diabetes [53].”
BackgroundPrevention of type 2 diabetes mellitus in women with previous gestational diabetes mellitus
Moon, J. H., Kwak, S. H., & Jang, H. C. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.203 · Cited by 93
COVID-19 pandemic: Impact on gestational diabetes mellitus prevalence
Zanardo, V., Tortora, D., Sandri, A., Severino, L., Mesirca, P., & Straface, G. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109149 · Cited by 93
Diversified gut microbiota in newborns of mothers with gestational diabetes mellitus
Su, M., Nie, Y., Shao, R., Duan, S., Jiang, Y., Wang, M., Xing, Z., Sun, Q., Liu, X., & Xu, W. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205695 · Cited by 103
Elliott, H. R., Sharp, G. C., Relton, C. L., & Lawlor, D. A. (2019) · Diabetologia · doi:10.1007/s00125-019-05011-8 · Cited by 88
Australian women's experiences of living with gestational diabetes
Morrison, M., LOWE, J. M., & Collins, C. E. (2013) · Women and Birth · doi:10.1016/j.wombi.2013.10.001 · Cited by 101
Screening for gestational diabetes mellitus and its prevalence in Bangladesh
Jesmin, S., Akter, S., Akashi, H., Al-Mamun, A., Rahman, M. A., Islam, M. M., Sohael, F., Okazaki, O., Moroi, M., Kawano, S., et al. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.024 · Cited by 92
Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus
Aslan, M., Çelik, Ö., Çelik, N., Türkçüoğlu, İ., Yılmaz, E., Karaer, A., Şimşek, Y., Çelik, E., & Aydın, S. (2011) · Endocrine · doi:10.1007/s12020-011-9577-8 · Cited by 95
“HAPO study has proposed fasting glucose level [91 mg/dl enough for the diagnosis of GDM, to decrease the risk of giving birth to a large for gestational age infant [29].”
BackgroundMcCance, D. R. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.07.009 · Cited by 109
Sheiner, E., Kapur, A., Retnakaran, R. R., Hadar, E., Poon, L. C., McIntyre, D. H., Divakar, H., Staff, A. C., Narula, J., Kihara, A., et al. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12926 · Cited by 102
Battarbee, A. N., Venkatesh, K. K., Aliaga, S. R., & Boggess, K. (2019) · Journal of Perinatology · doi:10.1038/s41372-019-0516-5 · Cited by 100
Reutrakul, S., Anothaisintawee, T., Herring, S. J., Balserak, B. I., Marc, I., & Thakkinstian, A. (2018) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2017.09.003 · Cited by 88
Gestational diabetes: weight gain during pregnancy and its relationship to pregnancy outcomes
Gou, B.-H., Guan, H.-M., Bi, Y.-X., & Ding, B.-J. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000036 · Cited by 91
Saravanan, P., Sukumar, N., Adaikalakoteswari, A., Goljan, I., Venkataraman, H., Gopinath, A., Bagias, C., Yajnik, C. S., Stallard, N., Ghebremichael-Weldeselassie, Y., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05510-7 · Cited by 91
Diabetes in pregnancy: health risks and management
Ali, S., & Dornhorst, A. (2011) · Postgraduate Medical Journal · doi:10.1136/pgmj.2010.109157 · Cited by 89
Law, K. P., Han, T.-L., Mao, X., & Zhang, H. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.02.018 · Cited by 95
Gestationsdiabetes (GDM) (Update 2023)
Kautzky‐Willer, A., Winhofer, Y., Kiss, H., Falcone, V., Berger, A., Lechleitner, M., Weitgasser, R., & Harreiter, J. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-023-02181-9 · Cited by 113
Advancements and challenges in generating accurate animal models of gestational diabetes mellitus
Pasek, R. C., & Gannon, M. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00425.2013 · Cited by 90
“In contrast, guidelines laid forth in 2010 by the International Association of Diabetes and Pregnancy Study Groups (IADPSG) recommend a diagnosis of GDM if any one of three blood glucose levels is abnormally high on a 2-h 75-g OGTT (Table 2) (66).”
MethodSyngelaki, A., Pastides, A., Kotecha, R., Wright, A., Akolekar, R., & Nicolaides, K. H. (2015) · Fetal Diagnosis and Therapy · doi:10.1159/000369970 · Cited by 83
The Emerging Role of Biomarkers in the Diagnosis of Gestational Diabetes Mellitus
Rodrigo, N., & Glastras, S. J. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7060120 · Cited by 84
Swaminathan, G., Swaminathan, A., & Corsi, D. J. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.25074 · Cited by 105
Popova, P., Kozyreva, A. A., Vasilyeva, L. B., Tkachuk, A., Vasukova, E. A., Anopova, A. D., Pustozerov, E., Gorelova, I. V., Кравчук, Е. Н., Li, O., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.628582 · Cited by 95
Gestational diabetes mellitus: Where are we now?
Ashwal, E., & Hod, M. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.01.021 · Cited by 110
Schreuder, M. F. (2012) · Pediatric Nephrology · doi:10.1007/s00467-012-2169-x · Cited by 89
“ment is diabetes: dysregulation of glucose is found in one in six pregnancies according to recent criteria of the International Association of Diabetes and Pregnancy Study Groups (IADSPG) [34].”
BackgroundThe maternal and fetal impacts of obesity and gestational diabetes on pregnancy outcome
Dennedy, M. C., & Dunne, F. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.06.001 · Cited by 88
Ethnic disparities in gestational diabetes
Yuen, L., Wong, V. W., & Simmons, D. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1040-2 · Cited by 88
García de la Torre, N., Assaf-Balut, C., Jiménez Varas, I., del Valle, L., Durán, A., Fuentes, M., del Prado, N., Bordiú, E., Valerio, J. J., Herraiz, M. A., et al. (2019) · Nutrients · doi:10.3390/nu11061210 · Cited by 88
De Souza, L. R., Berger, H., Retnakaran, R., Maguire, J. L., Nathens, A. B., Connelly, P. W., & Ray, J. G. (2016) · Diabetes Care · doi:10.2337/dc15-2027 · Cited by 84
“Using the IADPSG criteria for GDM (11), the association remained significant, albeit less pronounced.”
MethodInfluentialLu, L., Koulman, A., Petry, C. J., Jenkins, B., Matthews, L., Hughes, I. A., Acerini, C. L., Ong, K. K., & Dunger, D. B. (2016) · Diabetes Care · doi:10.2337/dc16-0863 · Cited by 87
“This has provided impetus for the International Association of Diabetes and Pregnancy Study Groups (IADPSG) to recommend universal screening for GDM via the 75g Oral Glucose Tolerance Test (OGTT) between 24-28 weeks gestation (3).”
MethodBenhalima, K., Van Crombrugge, P., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., De Block, C., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0556 · Cited by 85
Hod, M., Kapur, A., & McIntyre, H. D. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.01.206 · Cited by 81
Updated guidelines on screening for gestational diabetes
Gupta, Y., Kalra, B., Baruah, M. P., Singla, R., & Kalra, S. (2015) · International Journal of Women s Health · doi:10.2147/ijwh.s82046 · Cited by 97
Fasting Plasma Glucose at 24–28 Weeks to Screen for Gestational Diabetes Mellitus
Zhu, W.-W., Fan, L., Yang, H.-X., Kong, L.-Y., Su, S.-P., Wang, Z.-L., Hu, Y.-L., Zhang, M.-H., Sun, L.-Z., Mi, Y., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2465 · Cited by 88
Briley, A. L., Barr, S., Badger, S., Bell, R., Croker, H., Godfrey, K. M., Holmes, B., Kinnunen, T. I., Nelson, S. M., Oteng-Ntim, E., et al. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-74 · Cited by 87
Nitert, M. D., Barrett, H. L., Foxcroft, K., Tremellen, A., Wilkinson, S., Lingwood, B., Tobin, J. M., McSweeney, C., O’Rourke, P., McIntyre, H. D., et al. (2013) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-13-50 · Cited by 85
Metformin in Pregnancy: Mechanisms and Clinical Applications
Hyer, S., Balani, J., & Shehata, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071954 · Cited by 78
“pregnancy (overt diabetes) from transient manifestation of pregnancy related insulin resistance (gestational diabetes) [30].”
Pertot, T., Molyneaux, L., Tan, K., Ross, G. P., Yue, D. K., & Wong, J. (2011) · Diabetes Care · doi:10.2337/dc11-0499 · Cited by 87
“The rising incidence of GDM (2), coupled with the recent revision of GDM diagnostic criteria (3), is predicted to conservatively increase the incidence of GDM by w30%, with significant implications for the numbers requiring AIT and clinical workload (4).”
BackgroundNutrition therapy within and beyond gestational diabetes
Hernandez, T. L., Mande, A., & Barbour, L. A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.004 · Cited by 86
Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus
Khalafallah, A., Phuah, E., Al-Barazan, A. M., Nikakis, I., Radford, A., Clarkson, W., Trevett, C., Brain, T., Gebski, V., & Corbould, A. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011059 · Cited by 86
The clinical significance of overt diabetes in pregnancy
Wong, T., Ross, G. P., Jalaludin, B. B., & Flack, J. R. (2013) · Diabetic Medicine · doi:10.1111/dme.12110 · Cited by 86
Zheng, T., Ye, W., Wang, X., Li, X., Zhang, J., Little, J., Zhou, L., & Zhang, L. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2374-8 · Cited by 91
“,5mmol/L or 153mg/dL) by IADPSG criteria 2010 [31].”
Ruchat, S., & Mottola, M. F. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2402 · Cited by 86
“Criteria for the diagnostic of gestational diabetes mellitus [3,57,58] CDA 2008 (75-g OGTT) Comments ADA 2004 (100-g OGTT) Comments IADPSG 2011 (75-g OGTT) Comments Glucose (mmol/L) Current Canadian recommendations Glucose (mmol/L) Previous American recommendations Glucose (mmol/L) Current American recommendations Fas…”
BackgroundCardiovascular Health Among Pregnant Women, Aged 20 to 44 Years, in the United States
Perak, A. M., Ning, H., Khan, S. S., Van Horn, L. V., Grobman, W. A., & Lloyd‐Jones, D. M. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015123 · Cited by 86
Gestational Diabetes Mellitus Screening and Diagnosis
Sert, Ü. Y., & Ozgu-Erdinc, A. S. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_512 · Cited by 94
ADIPS 2020 guideline for pre‐existing diabetes and pregnancy
Rudland, V. L., Price, S., Hughes, R. C. E., Barrett, H. L., Lagstrom, J., Porter, C., Britten, F. L., Glastras, S. J., Fulcher, I., Wein, P., et al. (2020) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13265 · Cited by 90
Gestational diabetes: The public health relevance and approach
Veeraswamy, S., Vijayam, B., Gupta, V. K., & Kapur, A. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.04.024 · Cited by 96
Nirmalan, P. K. (2014) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2014/8062.4212 · Cited by 85
Muche, A. A., Olayemi, O. O., & Gete, Y. K. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2492-3 · Cited by 107
Chen, Q., Francis, E. C., Hu, G., & Chen, L. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.01.007 · Cited by 87
Cosson, E., Benbara, A., Pharisien, I., Nguyen, M. T., Revaux, A., Lormeau, B., Sandre-Banon, D., Assad, N., Pillegand, C., Valensi, P., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1428 · Cited by 85
Farren, M., Daly, N., McKeating, A., Kinsley, B., Turner, M. J., & Daly, S. (2017) · Diabetes Care · doi:10.2337/dc16-2449 · Cited by 80
Mørkrid, K., Jenum, A. K., Sletner, L., Vårdal, M. H., Waage, C. W., Nakstad, B., Vangen, S., & Birkeland, K. I. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0452 · Cited by 83
Glyburide transport across the human placenta
Schwartz, R. A., Rosenn, B., Aleksa, K., & Koren, G. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000672 · Cited by 83
Screening and diagnosis of gestational diabetes in India: A systematic review and meta-analysis
Li, K. T., Naik, S., Alexander, M., & Mathad, J. S. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1131-1 · Cited by 83
Gestationsdiabetes (GDM) (Update 2019)
Kautzky-Willer, A., Harreiter, J., Winhofer-Stöckl, Y., Bancher-Todesca, D., Berger, A., Repa, A., Lechleitner, M., & Weitgasser, R. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-018-1419-8 · Cited by 73
Wang, Q., Lu, X., Li, C., Zhang, W., Lv, Y., Wang, L., Wu, L., Li, M., Fan, Y., Ding, H., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109501 · Cited by 85
Gopalakrishnan, V, Singh, R., Pradeep, Y., Kapoor, D., Rani, A., Pradhan, S., Bhatia, E., & Yadav, S. (2015) · Journal of Postgraduate Medicine · doi:10.4103/0022-3859.159306 · Cited by 75
“[1,2] The HAPO study established that fetal and maternal complications were strongly associated with maternal hyperglycemia.”
Hirst, J. E., Tran, T. S., Do, M. A. T., Rowena, F., Morris, J. M., & Jeffery, H. E. (2012) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-12-81 · Cited by 81
“This rises to 20% if the proposed universal International Diabetes in Pregnancy Study group criteria [13] were applied [14].”
BackgroundNew Concepts in Diabetic Embryopathy
Zhao, Z., & Reece, E. A. (2013) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2013.03.017 · Cited by 88
Capula, C., CHIEFARI, E. D., Vero, A., FOTI, D. P., Brunetti, A., & Vero, R. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.05.008 · Cited by 94
The Born in Guangzhou Cohort Study (BIGCS)
Qiu, X., Lu, J., He, J., Lam, K.-B. H., Shen, S., Guo, Y. G., Kuang, Y., Yuan, M., Qiu, L., Chen, N., et al. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0239-x · Cited by 87
“Based on the findings from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study [14], the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recommended a new set of criteria for diagnosing GDM in 2010 [15], resulting in higher diagnosed Table 2 Comparison of characteristics among wo…”
Li-zhen, L., Yun, X., Xiao-Dong, Z., Shu-bin, H., Zi-lian, W., Adrian Sandra, D., & Bin, L. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-023014 · Cited by 77
The association of gestational diabetes mellitus with fetal birth weight
Yang, Y., Wang, Z., Mo, M., Muyiduli, X., Wang, S., Li, M., Jiang, S. S., Wu, Y., Shao, B., Shen, Y., et al. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.04.008 · Cited by 86
Huhn, E. A., Rossi, S. W., Hoesli, I., & Göbl, C. S. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00696 · Cited by 80
Godfrey, K. M., Barton, S. J., El‐Heis, S., Kenealy, T. W., Nield, H., Baker, P. N., Chong, Y. S., Cutfield, W. S., Chan, S., NiPPeR Study Group, et al. (2021) · Diabetes Care · doi:10.2337/dc20-2515 · Cited by 85
Shang, M., & Li, L. (2013) · Journal of Perinatology · doi:10.1038/jp.2013.143 · Cited by 94
Cosson, E., Baz, B., Gary, F., Pharisien, I., Nguyen, M. T., Sandre-Banon, D., Jaber, Y., Cussac-Pillegand, C., Banu, I., Carbillon, L., et al. (2017) · Diabetes Care · doi:10.2337/dc17-0369 · Cited by 86
McIntyre, H. D., Jensen, D. M., Jensen, R. C., Kyhl, H. B., Jensen, T. K., Glintborg, D., & Andersen, M. (2018) · Diabetes Care · doi:10.2337/dc17-2393 · Cited by 81
Zhang, R., Han, S., Chen, G.-C., Li, Z.-N., Silva-Zolezzi, I., Parés, G. V., Wang, Y., & Qin, L.-Q. (2018) · European Journal of Nutrition · doi:10.1007/s00394-016-1306-x · Cited by 81
McIntyre, H. D., Gibbons, K. S., Ma, R. C. W., Tam, W. H., Sacks, D. A., Lowe, J., Madsen, L. R., & Catalano, P. M. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108353 · Cited by 81
Cosson, E., Carbillon, L., & Valensi, P. (2017) · Journal of Diabetes Research · doi:10.1155/2017/8921712 · Cited by 82
Corcoy, R., Mendoza, L. C., Simmons, D. S., Desoyé, G., Adelantado, J. M., Chico, A. I., Devlieger, R., Assche, A. V., Galjaard, S., Timmerman, D., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.04.006 · Cited by 92
Bozkurt, L., Göbl, C. S., Pfligl, L., Leitner, K., Bancher-Todesca, D., Luger, A., Baumgartner-Parzer, S., Pacini, G., & Kautzky-Willer, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4055 · Cited by 79
Metadata
- Authors
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel
- Corresponding author
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-03-01
- Volume
- 33
- Issue
- 3
- Pages
- 676-682
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2827530
- OpenAlex
- W2616235706
- Cited by
- 5,390
- References
- 56
- Citations by year
- 2026: 314 · 2025: 377 · 2024: 446 · 2023: 423 · 2022: 494 · 2021: 507 · 2020: 425 · 2019: 350 · 2018: 367 · 2017: 297 · 2016: 274 · 2015: 296 · 2014: 235 · 2013: 203 · 2012: 167
- FWCI
- 250.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- American Diabetes Association
- Kaiser Permanente
- National Institute of Child Health and Human Development (R01‐HD34242, R01-HD-34243)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD-34243, R01-HD-34242, R01HD034242, R01HD034243)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- gestational diabetes mellitus, hyperglycemia in pregnancy, IADPSG criteria, perinatal outcomes, maternal glycemia, diagnostic thresholds
- MeSH terms
- Female, Health Planning Guidelines, Humans, Hyperglycemia, International Cooperation, Pregnancy, Pregnancy Complications, Pregnancy in Diabetics, Societies, Medical, Diabetes, Gestational, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.